Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy AxoGen stock | $14.61

Learn how to easily invest in AxoGen stock.

AxoGen Inc is a medical devices business based in the US. AxoGen shares (AXGN) are listed on the NASDAQ and all prices are listed in US Dollars. AxoGen employs 346 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in AxoGen

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AXGN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

AxoGen stock price (NASDAQ: AXGN)

Use our graph to track the performance of AXGN stocks over time.

AxoGen shares at a glance

Information last updated 2021-10-17.
Latest market close$14.61
52-week range$11.54 - $23.49
50-day moving average $15.94
200-day moving average $18.73
Wall St. target price$27.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.54

Buy AxoGen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AxoGen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AxoGen price performance over time

Historical closes compared with the close of $14.61 from 2021-10-20

1 week (2021-10-10) N/A
1 month (2021-09-21) -6.82%
3 months (2021-07-21) -27.57%
6 months (2021-04-21) -24.26%
1 year (2020-10-21) 11.61%
2 years (2019-10-21) 14.77%
3 years (2018-10-19) 33.51
5 years (2016-10-21) 63.24%

AxoGen financials

Revenue TTM $130.5 million
Gross profit TTM $90.7 million
Return on assets TTM -6.5%
Return on equity TTM -18.49%
Profit margin -16.89%
Book value $2.87
Market capitalisation $563.8 million

TTM: trailing 12 months

Shorting AxoGen shares

There are currently 945,101 AxoGen shares held short by investors – that's known as AxoGen's "short interest". This figure is 9.7% down from 1.0 million last month.

There are a few different ways that this level of interest in shorting AxoGen shares can be evaluated.

AxoGen's "short interest ratio" (SIR)

AxoGen's "short interest ratio" (SIR) is the quantity of AxoGen shares currently shorted divided by the average quantity of AxoGen shares traded daily (recently around 120702.55427842). AxoGen's SIR currently stands at 7.83. In other words for every 100,000 AxoGen shares traded daily on the market, roughly 7830 shares are currently held short.

However AxoGen's short interest can also be evaluated against the total number of AxoGen shares, or, against the total number of tradable AxoGen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AxoGen's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 AxoGen shares in existence, roughly 20 shares are currently held short) or 0.0276% of the tradable shares (for every 100,000 tradable AxoGen shares, roughly 28 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against AxoGen.

Find out more about how you can short AxoGen stock.

AxoGen share dividends

We're not expecting AxoGen to pay a dividend over the next 12 months.

Have AxoGen's shares ever split?

AxoGen's shares were split on a 105:100 basis on 10 July 1994. So if you had owned 100 shares the day before before the split, the next day you'd have owned 105 shares. This wouldn't directly have changed the overall worth of your AxoGen shares – just the quantity. However, indirectly, the new 4.8% lower share price could have impacted the market appetite for AxoGen shares which in turn could have impacted AxoGen's share price.

AxoGen share price volatility

Over the last 12 months, AxoGen's shares have ranged in value from as little as $11.54 up to $23.49. A popular way to gauge a stock's volatility is its "beta".

AXGN.US volatility(beta: 0.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AxoGen's is 0.7534. This would suggest that AxoGen's shares are less volatile than average (for this exchange).

AxoGen overview

AxoGen, Inc. , together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc.

Frequently asked questions

What percentage of AxoGen is owned by insiders or institutions?
Currently 4.46% of AxoGen shares are held by insiders and 81.573% by institutions.
How many people work for AxoGen?
Latest data suggests 346 work at AxoGen.
When does the fiscal year end for AxoGen?
AxoGen's fiscal year ends in December.
Where is AxoGen based?
AxoGen's address is: 13631 Progress Boulevard, Alachua, FL, United States, 32615
What is AxoGen's ISIN number?
AxoGen's international securities identification number is: US05463X1063
What is AxoGen's CUSIP number?
AxoGen's Committee on Uniform Securities Identification Procedures number is: 05463X106

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site